SCRI Clinical Trials Symposium: Day 1 of ICYMI
Singapore Clinical Research Institute (SCRI) posted on LinkedIn:
“The SCRI Clinical Trials Symposium programme continued with a series of impactful keynote presentations, featuring leading experts across parallel panel tracks with so much to learn!
ICYMI here’s a recap of day 1, Tuesday 30 July 2024:
Sir Jeremy Farrar, Chief Scientist, World Health Organization, shared how clinical trials played a pivotal role in our collective response to the pandemic. The identification and development of effective treatments were made possible by an unprecedented global effort in clinical research.
Prof Kenneth Mak, Director-General of Health, Ministry of Health, Singapore, spoke about the importance of building a robust infrastructure to conduct clinical trials. Having the capacity to support trials is crucial in ensuring a sustainable and high value healthcare ecosystem in Singapore.
A plenary with Prof Mak, Adj A/Prof Danny Soon, Mr Adrian Yap, A/Prof David SP Tan, Dr Daph Gardner and Ms Hwee Tee Poh, explored the value proposition of clinical trials from a multi-faceted perspective, such as access to new treatments, evidence-based practice and innovation.
A/Prof Edwin Chan, Prof David Matchar, Adj A/Prof Hong Choon Oh and Adj Prof Kelvin Bryan Tan, discussed the different ways to proactively integrate the research mindset with healthcare policy making to optimise the use of resources.
At this Takeda-sponsored track, Prof Li Yang Hsu, Ms Lara Grace Marzo, Dr Po-Ying Chia and Prof Jenny Low, highlighted the factors that influence clinical trial selection. Using a Dengue trial as a use case, they shared how clinical sites in Singapore was an apt choice due to the KOLs and support available.
Ms Ai Ling Sim-Devadas, Ms Nidhi Swarup, Dr Nikki K. and Ms Alison Evans, shared the significance of patient advocacy groups in fostering a deeper understanding of patient needs, enhancing the relevance of research and speeding up the development of innovative therapies for improved healthcare.
Ms Veronika Brandmair, Ms Serene Ong, Prof Derek Hausenloy, Dr Pramod Kashid and Mr Henning Lux highlighted the impact of decentralised clinical trials in revolutionising clinical research by tapping on digital technologies to enhance accessibility and accelerate trial progress.
We look forward to the rest of Day 2 which will touch on topics such as:
Improving collaboration across borders to advance clinical research for better health outcomes.
Utilising adaptive clinical trial designs to enhance efficiency in clinical research
Navigating challenges and considerations when designing a trial for AI technologies
Thank you for having joined us at the symposium thus far!”
Source: Singapore Clinical Research Institute (SCRI)/LinkedIn
